Aperio Group LLC grew its holdings in LifePoint Health Inc (NASDAQ:LPNT) by 59.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 72,315 shares of the company’s stock after purchasing an additional 26,892 shares during the quarter. Aperio Group LLC owned 0.19% of LifePoint Health worth $3,399,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Schwab Charles Investment Management Inc. raised its holdings in LifePoint Health by 1.4% in the first quarter. Schwab Charles Investment Management Inc. now owns 171,904 shares of the company’s stock valued at $8,080,000 after acquiring an additional 2,361 shares in the last quarter. Chicago Equity Partners LLC acquired a new stake in LifePoint Health in the first quarter valued at approximately $953,000. Quantitative Systematic Strategies LLC acquired a new stake in LifePoint Health in the first quarter valued at approximately $418,000. LSV Asset Management raised its holdings in LifePoint Health by 6.6% in the first quarter. LSV Asset Management now owns 2,246,057 shares of the company’s stock valued at $105,564,000 after acquiring an additional 138,600 shares in the last quarter. Finally, Swiss National Bank raised its holdings in LifePoint Health by 3.3% in the first quarter. Swiss National Bank now owns 69,800 shares of the company’s stock valued at $3,281,000 after acquiring an additional 2,200 shares in the last quarter.
LPNT has been the topic of several analyst reports. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $50.00 target price on shares of LifePoint Health in a report on Friday, February 23rd. Morgan Stanley reissued an “equal weight” rating and set a $46.00 price objective (down previously from $50.00) on shares of LifePoint Health in a report on Monday, February 26th. Credit Suisse Group reissued a “neutral” rating and set a $48.00 price objective (down previously from $54.00) on shares of LifePoint Health in a report on Monday, February 26th. Robert W. Baird reissued a “buy” rating and set a $54.00 price objective on shares of LifePoint Health in a report on Tuesday, March 27th. Finally, Mizuho began coverage on shares of LifePoint Health in a report on Friday, March 23rd. They set a “neutral” rating on the stock. Two analysts have rated the stock with a sell rating, eleven have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $54.87.
LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Friday, May 4th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.13 by $0.09. The business had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.62 billion. LifePoint Health had a net margin of 0.48% and a return on equity of 6.56%. The company’s quarterly revenue was down 1.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.07 EPS. analysts anticipate that LifePoint Health Inc will post 4.3 earnings per share for the current year.
LifePoint Health Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.